Literature DB >> 16804689

The influence of wire localisation for non-palpable breast lesions on visualisation of the sentinel node.

J E Jansen1, J Bekker, M J de Haas, F A van der Weel, G H M Verberne, L M Budel, L G B A Quekel, J M H de Klerk.   

Abstract

PURPOSE: In our clinic, patients with occult breast lesions are treated with a sentinel node biopsy combined with wire-guided tumour excision. The aim of this retrospective study was to determine the influence of the sequence of wire localisation and sentinel node procedure on visualisation of the sentinel node.
METHODS: A total of 136 patients had a wire-guided tumour excision combined with a sentinel node procedure. Sixty-six patients had guide wire localisation prior to the sentinel node procedure. Seventy patients had sentinel node visualisation before insertion of the guide wire.
RESULTS: The sentinel node was visualised in 41 (62%) of the patients who first underwent guide wire localisation. In the group of patients who underwent visualisation of the sentinel node before placement of the guide wire, the sentinel node was visualised in 62 (89%). This is a significant difference in visualisation (p<0.001).
CONCLUSION: This study shows that guide wire localisation prior to the sentinel node procedure negatively influences visualisation of the sentinel node.

Entities:  

Mesh:

Year:  2006        PMID: 16804689     DOI: 10.1007/s00259-006-0119-1

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  21 in total

1.  Lymphoscintigraphy and sentinel node localization in breast cancer patients: a comparison between 1-day and 2-day protocols.

Authors:  H W Yeung; H S Cody III; A Turlakow; E R Riedel; J Fey; M Gonen; R Nuñez; S D Yeh; S M Larson
Journal:  J Nucl Med       Date:  2001-03       Impact factor: 10.057

Review 2.  Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy.

Authors:  P J Tanis; O E Nieweg; R A Valdés Olmos; B B Kroon
Journal:  J Am Coll Surg       Date:  2001-03       Impact factor: 6.113

3.  Factors predicting failure to identify a sentinel lymph node in breast cancer.

Authors:  Anees B Chagpar; Robert C Martin; Charles R Scoggins; David J Carlson; Alison L Laidley; Souzan E El-Eid; Terre Q McGlothin; Robert D Noyes; Phillip B Ley; Todd M Tuttle; Kelly M McMasters
Journal:  Surgery       Date:  2005-07       Impact factor: 3.982

4.  Impact of axillary nodal metastases on lymphatic mapping and sentinel lymph node identification rate in patients with early stage breast cancer.

Authors:  Ettore Pelosi; Ada Ala; Marilena Bellò; Anastasios Douroukas; Giuseppe Migliaretti; Ester Berardengo; Teresio Varetto; Riccardo Bussone; Gianni Bisi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04-19       Impact factor: 9.236

5.  An approach for the treatment of penile carcinoma.

Authors:  R M Cabanas
Journal:  Cancer       Date:  1977-02       Impact factor: 6.860

6.  Radioguided localisation of non-palpable breast lesions and simultaneous sentinel lymph node mapping.

Authors:  Alfredo Barros; Maria Aparecida Cardoso; Peng Yong Sheng; Paulo Aguirre Costa; Christina Pelizon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-10-10       Impact factor: 9.236

7.  Sentinel Node Biopsy in Breast Cancer: An Overview.

Authors:  Douglas Reintgen; Rosemary Giuliano; Charles E. Cox
Journal:  Breast J       Date:  2000-10       Impact factor: 2.431

8.  Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy.

Authors:  S M Feldman; D N Krag; R K McNally; B B Moor; D L Weaver; P Klein
Journal:  J Am Coll Surg       Date:  1999-03       Impact factor: 6.113

9.  Effects of a metastatic (13762) and nonmetastatic (R3230AC) mammary adenocarcinoma on radiocolloid localization in regional lymph nodes in Fischer 344 rats.

Authors:  G N Ege; J B Nold; R R Eng; A Durakovic; J J Conklin
Journal:  J Reticuloendothel Soc       Date:  1983-12

10.  Optimised nuclear medicine method for tumour marking and sentinel node detection in occult primary breast lesions.

Authors:  C De Cicco; G Trifirò; M Intra; G Marotta; A Ciprian; A Frasson; G Prisco; A Luini; G Viale; G Paganelli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-11-29       Impact factor: 9.236

View more
  6 in total

1.  Radioguided localisation (ROLL) of non-palpable breast lesions and simultaneous sentinel lymph node biopsy (SNOLL): the experience of the European Institute of Oncology.

Authors:  Mattia Intra; Concetta de Cicco; Oreste Gentilini; Alberto Luini; Giovanni Paganelli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06       Impact factor: 9.236

2.  Lymphoscintigraphic and intraoperative detection of sentinel lymph nodes.

Authors:  Ali T Akpinar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-04-20       Impact factor: 9.236

3.  Anatomical breast imaging-derived parameters do not provide incremental information in prediction of nonvisualization of sentinel lymph nodes on lymphoscintigraphy.

Authors:  Youssef Chahid; Hein J Verberne; Edwin Poel; N Harry Hendrikse; Jan Booij
Journal:  Nucl Med Commun       Date:  2022-05-18       Impact factor: 1.698

4.  Staging the axilla with selective sentinel node biopsy in patients with previous excision of non-palpable and palpable breast cancer.

Authors:  R Ruano; M Ramos; J R Garcia-Talavera; E Serrano; A De Arriba; J Gonzalez-Orus; M Iglesias; M C Macias
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-02-12       Impact factor: 9.236

5.  Comparison of a 1-day and a 2-day protocol for lymphatic mapping and sentinel lymph node biopsy in patients with nonpalpable breast cancer.

Authors:  S van Esser; M Hobbelink; J W Van Isselt; W P Th M Mali; I H M Borel Rinkes; R van Hillegersberg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03-25       Impact factor: 9.236

Review 6.  The sentinel node in breast cancer.

Authors:  Conor D Collins
Journal:  Cancer Imaging       Date:  2008-10-04       Impact factor: 3.909

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.